Healthcare Services

Global Gene Therapy Clinical Trial Services Market Forecast Highlighting Expansion And Competitive Dynamics

May 28, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Does The Forecasted Market Size Of The Gene Therapy Clinical Trial Services Market Compare Between 2026 And 2030?

The gene therapy clinical trial services market size has experienced rapid growth in recent years. It is projected to expand from $1.82 billion in 2025 to $2.18 billion in 2026, achieving a compound annual growth rate (CAGR) of 19.4%. Historically, this growth can be ascribed to several factors, including heightened investment in gene therapy research and development, the expansion of early-stage gene therapy pipelines, an increase in collaborations between biotechnology firms and contract research organizations (CROs), the increasing complexity of gene therapy trial protocols, and enhanced regulatory scrutiny concerning advanced therapies.

The gene therapy clinical trial services market size is anticipated to experience rapid growth in the coming years, projected to reach $4.39 billion by 2030, at a compound annual growth rate (CAGR) of 19.1%. This expansion during the forecast period is driven by factors such as a rising number of late-stage gene therapy trials, increasing demand for global trial execution capabilities, the expansion of rare disease gene therapy programs, a growing reliance on digital trial management platforms, and an enhanced focus on accelerated regulatory approvals. Significant trends for the forecast period include a heightened demand for specialized gene therapy trial management, the increasing adoption of decentralized and hybrid trial models, a stronger emphasis on advanced cold chain and logistics support, the broadening of patient-centric trial design approaches, and an enhanced focus on regulatory and data integrity services.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27292&type=smp

Which Major Factors Are Contributing To The Development Of The Gene Therapy Clinical Trial Services Market?

The rising need for personalized medicine is anticipated to drive the expansion of the gene therapy clinical trial services market in the future. This medical strategy customizes treatments based on unique patient attributes, including genetic makeup, biomarkers, and lifestyle elements. The demand for personalized medicine is escalating, spurred by innovations in genomics and biotechnology that facilitate more accurate therapeutic targeting. Gene therapy clinical trial services aid personalized medicine by examining patient-specific genetic data and adapting treatments, leveraging biomarker analysis and companion diagnostics to refine therapy for every person, thus improving both safety and efficacy. An example demonstrating this trend is that in February 2024, the Personalized Medicine Coalition, a US-based hospital and health care organization, reported that the FDA greenlit 16 novel personalized treatments for patients with rare diseases in 2023, an increase from 6 approvals in 2022. Consequently, the heightened demand for personalized medicine is a key factor propelling the expansion of the gene therapy clinical trial services market.

What Are The Major Segment Categories Within The Gene Therapy Clinical Trial Services Market?

The gene therapy clinical trial services market covered in this report is segmented –

1) By Type: Clinical Trial Design And Planning, Supply And Logistics Services, Regulatory Services, Data Management And Biostatistics, Site Management And Monitoring, Other Types

2) By Application: Oncology, Hematology, Endocrine or Metabolic Disorders, Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Applications

3) By End-User: Pharmaceutical Companies, Biotechnology Companies, Academic Institutions, Government Research Institutes, Contract Research Organizations (CROs)

Subsegments:

1) By Clinical Trial Design And Planning: Protocol Development, Feasibility Studies, Patient Recruitment Strategy Design

2) By Supply And Logistics Services: Cold Chain Management, Investigational Product Packaging And Labeling, Controlled-Temperature Storage

3) By Regulatory Services: Regulatory Consulting And Strategy, Ethics Committee Submissions, Regulatory Compliance Monitoring

4) By Data Management And Biostatistics: Clinical Data Capture And Database Design, Data Validation And Quality Control, Statistical Analysis And Modeling

5) By Site Management And Monitoring: Site Selection And Qualification, Investigator Training And Support, On-Site Monitoring Visits

6) By Other Types: Pharmacovigilance And Safety Reporting, Quality Assurance And Auditing, Patient Engagement And Retention

What Trends Are Driving Changes In The Gene Therapy Clinical Trial Services Market?

Major companies operating in the gene therapy clinical trial services market are concentrating on developing innovative solutions, such as the long-term follow-up (LTFU) model for cell and gene therapy (CGT) trials. This focus is intended to accelerate the overall trial process while maintaining regulatory compliance and safety standards. A Long-Term Follow-Up (LTFU) model for cell and gene therapy (CGT) trials functions as a structured framework designed to observe patients over an extended period, often up to 15 years after receiving a CGT treatment. For example, in May 2025, Medable Inc., a US-based SaaS company, launched a digital-first Long-Term Follow-Up (LTFU) model specifically engineered for cell and gene therapy (CGT) trials. It supports cell and gene therapy trials by minimizing patient and site burdens while ensuring scientific rigor across the FDA-required 15-year monitoring period. This model also enhances patient access, retention, and data continuity through remote and hybrid follow-up methods, thereby improving long-term safety and efficacy monitoring.

Who Are The Major Companies Operating In The Gene Therapy Clinical Trial Services Market?

Major companies operating in the gene therapy clinical trial services market are Thermo Fisher Scientific Inc., Sharp Services LLC, Labcorp, Pharmaceutical Product Development LLC, ICON plc, Syneos Health Inc., WuXi AppTec, Franklin Biolabs, Catalent Inc., Charles River Laboratories International Inc., Parexel International Corporation, Medpace Holdings Inc., Precision Medicine Group LLC, Worldwide Clinical Trials, IQVIA Holdings Inc., TFS HealthScience, Veristat LLC, Novotech Health Holdings Pte Limited, Covance Inc., PPD Clinical Research Services, PRA Health Sciences Inc.

Access The Complete Gene Therapy Clinical Trial Services Market Report:

https://www.thebusinessresearchcompany.com/report/gene-therapy-clinical-trial-services-global-market-report

Which Region Is The Primary Market For The Gene Therapy Clinical Trial Services Market?

North America was the largest region in the gene therapy clinical trial services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gene therapy clinical trial services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Gene Therapy Clinical Trial Services Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=27292&type=smp

Browse Through More Reports Similar to the Global Gene Therapy Clinical Trial Services Market 2026, By The Business Research Company

Nucleic Acid Based Gene Therapy Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/nucleic-acid-based-gene-therapy-global-market-report

Genes Therapy Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

Cell And Genes Therapy Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-and-genes-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795